Diretrizes

Diretriz | Amostra de tecido via endoscopia – Parte 1: tratos gastrintestinal alto e hepatopancreatobiliar.

26 Nov, 2021 | 11:34h

Endoscopic tissue sampling – Part 1: Upper gastrointestinal and hepatopancreatobiliary tracts. European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Endoscopy

Diretriz | Amostra de tecido via endoscopia – Parte 2: trato gastrintestinal baixo.

26 Nov, 2021 | 11:32h

Endoscopic tissue sampling – Part 2: Lower gastrointestinal tract. European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Endoscopy

Diretriz provisória da OMS sobre a vacinação de crianças e adolescentes contra a COVID-19.

25 Nov, 2021 | 15:20h

Interim statement on COVID-19 vaccination for children and adolescents – World Health Organization

OMS lança o relatório 2021 de resistência do HIV a medicamentos.

25 Nov, 2021 | 15:10h

Comunicado de imprensa: WHO releases HIV drug resistance report 2021 – World Health Organization

Relatório: HIV drug resistance report 2021 – World Health Organization

Ficha técnica: HIV Drug Resistance – World Health Organization

Comentário no Twitter

🆕 Check out WHO’s latest HIV Drug Resistance Report & find out:

💊 how drug resistance is growing
💊 steps countries are taking to ensure people will receive effective medicine to treat & prevent HIVhttps://t.co/76teEHFrVV

— World Health Organization (WHO) (@WHO) November 24, 2021

Diretriz para o diagnóstico laboratorial da deficiência de ferro em adultos (exceto gestantes) e crianças.

25 Nov, 2021 | 15:07h

Guideline for the laboratory diagnosis of iron deficiency in adults (excluding pregnancy) and children – British Journal of Haematology

Diretriz do Consenso de Especialistas ACSM | Prevenção de lesões e desempenho durante a prática de exercícios em climas frios.

25 Nov, 2021 | 15:06h

ACSM Expert Consensus Statement: Injury Prevention and Exercise Performance during Cold-Weather Exercise – Current Sports Medicine Reports

Diretriz de prática clínica para o tratamento de ascite maligna.

25 Nov, 2021 | 15:05h

Clinical practice guideline for the treatment of malignant ascites: section summary in Clinical Practice Guideline for peritoneal dissemination (2021) – International Journal of Clinical Oncology

OMS emite diretrizes sobre o tratamento de crianças com síndrome inflamatória multissistêmica associada a COVID-19.

24 Nov, 2021 | 11:37h

Comunicado de imprensa: WHO issues guidelines on the treatment of children with multisystem inflammatory syndrome associated with COVID-19 – World Health Organization

Diretriz: Living guidance for clinical management of COVID-19 – World Health Organziation

Conteúdos relacionados:

An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2.

Ten Things to Know About Multisystem Inflammatory Syndrome in Children (MIS-C).

Cohort study: long term follow-up showed most patients with post–COVID-19 Multisystem Inflammatory Syndrome in Children had good outcomes with no significant medium- or long-term sequelae.

Kawasaki Disease and Multisystem Inflammatory Syndrome in Children: An Overview and Comparison.

Cohort study: Six month follow-up of Multisystem Inflammatory Syndrome in Children.

Cohort study: Among children with Multisystem Inflammatory Syndrome (MIS-C) associated with Covid-19, there was no evidence that recovery differed after primary treatment with intravenous immune globulin (IVIG) alone, IVIG plus glucocorticoids, or glucocorticoids alone.

Cohort study: Among children with Multisystem Inflammatory Syndrome (MIS-C) associated with Covid-19, initial treatment with intravenous immune globulin (IVIG) plus glucocorticoids was associated with a lower risk of new or persistent cardiovascular dysfunction than IVIG alone.

Cohort study showed that the incidence of Multisystem Inflammatory Syndrome in Children (MIS-C) was 316 persons per 1 000 000 SARS-CoV-2 infections in persons younger than 21 years. The incidence was higher among Black, Hispanic or Latino, and Asian or Pacific Islander persons.

Cohort study showed good recovery for most children 6 months after Pediatric Inflammatory Multisystem Syndrome (PIMS-TS) associated with SARS-CoV-2.

Epidemiology of Multisystem Inflammatory Syndrome in Children: A Step Closer to Understanding Who, Where, and When

Neurologic involvement in children and adolescents with COVID-19 or Multisystem Inflammatory Syndrome

Clinical Update: Acute covid-19 and multisystem inflammatory syndrome in children

Differences in characteristics and outcomes of children and adolescents with Multisystem Inflammatory Syndrome in Children (MIS-C) vs. severe acute COVID-19

Cutaneous findings in SARS-CoV-2-associated Multisystem Inflammatory Disease in Children (MIS-C)

SR: Multisystem inflammatory syndrome in children related to COVID-19

Observational study: The combination of Immunoglobulins + Methylprednisolone was associated with a better course of fever compared to Immunoglobulins alone in Multisystem Inflammatory Syndrome in children

ACR Guidance for pediatric patients with multisystem inflammatory syndrome in children associated with SARS‐CoV‐2

New systematic review of Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 infection summarizes the clinical features, management, and outcomes of the disease, showing favorable outcomes for the majority of children

Atualização em prática clínica da AGA sobre tratamento da dor gastrintestinal crônica nos distúrbios de interação intestino–cérebro.

24 Nov, 2021 | 11:30h

AGA Clinical Practice Update on Management of Chronic Gastrointestinal Pain in Disorders of Gut–Brain Interaction: Expert Review – Clinical Gastroenterology and Hepatology

Três sociedades neurológicas, incluindo a AAN, emitem forte diretriz de posicionamento sobre o aducanumabe.

24 Nov, 2021 | 11:25h

Three Neurologic Societies, Including the AAN, Issue Strong Position Statement on Aducanumab – Neurology Today

Ver diretriz: Decisions With Patients and Families Regarding Aducanumab in Alzheimer Disease, With Recommendations for Consent: AAN Position Statement – Neurology